Jun 23, 2026 07:00AM
Jun 23, 2026 07:00AM
Jun 16, 2026 07:02AM
Jun 16, 2026 07:00AM
Dec 22, 2025 07:06AM
Mar 20, 2025 07:00AM
Nov 4, 2024 07:30AM Actinium Pharmaceuticals Appoints Accomplished Biopharma Industry Executive June Almenoff, M.D., Ph.D. to its Board of Directors
Jul 9, 2024 07:02AM
Jul 9, 2024 07:00AM
Jun 24, 2024 04:02PM
Jun 24, 2024 04:01PM
Oct 31, 2023 07:02AM
Oct 31, 2023 07:00AM
Sep 12, 2023 07:00AM Avalo Therapuetics (AVTX) Enters into Agreement to Divest AVTX-800 Series
Sep 12, 2023 07:00AM
Aug 4, 2022 07:30AM
Aug 4, 2022 07:30AM
Jul 7, 2022 09:26AM
May 5, 2022 07:30AM
May 5, 2022 07:30AM
Mar 2, 2022 07:30AM Avalo Therapeutics Reports 2021 Financial Results and Provides Business Updates
Mar 2, 2022 07:30AM
Feb 17, 2022 07:34AM
Feb 17, 2022 07:32AM
Feb 17, 2022 07:30AM
Feb 17, 2022 07:30AM
Jan 6, 2022 07:30AM
Jan 6, 2022 07:30AM Avalo Reports Positive Phase 1b Results for AVTX-002 in Moderate to Severe Crohn's Disease Patients and Presents Additional Program Updates at 2022 Investor Event
Jan 6, 2022 07:30AM
Nov 9, 2021 04:01PM
Nov 9, 2021 04:01PM
Aug 26, 2021 07:30AM
Aug 26, 2021 07:30AM

324,144 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All